Biliary excretion of platinum in rats after administration of cisplatin and aqua(1,1-bis(aminomethyl)-cyclohexane)sulfatoplatinum(II) (spiroplatin, TNO-6).

[1]  L. V. van Putten,et al.  Preclinical studies on toxicity, antitumour activity and pharmacokinetics of cisplatin and three recently developed derivatives. , 1984, European journal of cancer & clinical oncology.

[2]  H. Pinedo,et al.  Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin. , 1984, Cancer treatment reports.

[3]  B. Issell,et al.  New platinum complexes in clinical trials. , 1983, Cancer treatment reviews.

[4]  H. Pinedo,et al.  Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implications. , 1982, European journal of cancer & clinical oncology.

[5]  J. Fortner,et al.  Pharmacokinetics of cisplatin regional hepatic infusions. , 1982, American journal of clinical oncology.

[6]  DeSimone Pa,et al.  Effect of a forced diuresis on the distribution and excretion (via urine and bile) of 195mplatinum when given as 195mplatinum cis-dichlorodiammineplatinum(II). , 1979 .

[7]  R. Hughes,et al.  Molecular weight as a factor in the excretion of monoquaternary ammonium cations in the bile of the rat, rabbit and guinea pig. , 1973, The Biochemical journal.

[8]  J. Mcvie,et al.  Clinical Experience with 1, 1-Diaminomethylcyclohexane (Sulphato) Platinum (II) (TNO-6) , 1984 .

[9]  Z. Siddik,et al.  Biliary Excretion, Renal Handling and Red Cell Uptake of Cisplatin and CBDCA in Animals , 1984 .

[10]  W. Rose,et al.  Antitumor activity and toxicity of cisplatin analogs. , 1982, Cancer treatment reports.

[11]  W. G. Levine.  Biliary excretion of drugs and other xenobiotics. , 1978, Annual review of pharmacology and toxicology.